Vistagen Therapeutics, Inc. (VTGN)
4.55
+0.26
(+6.06%)
USD |
NASDAQ |
Dec 09, 16:00
4.52
-0.03
(-0.66%)
Pre-Market: 08:44
Vistagen Therapeutics Shareholders Equity (Quarterly): 66.34M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 466.00M |
| XOMA Royalty Corp. | 107.96M |
| Omeros Corp. | -220.48M |
| GeoVax Labs, Inc. | 4.907M |
| Daré Bioscience, Inc. | 2.858M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.93M |
| Total Liabilities (Quarterly) | 14.59M |
| Debt to Equity Ratio | 0.0281 |
| Current Ratio | 5.785 |
| Net Debt Paydown Yield | 0.04% |